| 000 | 01578 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514220317.0 | ||
| 264 | 0 | _c20050628 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0886-022X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobles, N R | |
| 245 | 0 | 0 |
_aLercanidipine in patients with chronic renal failure: the ZAFRA study. _h[electronic resource] |
| 260 |
_bRenal failure _c2005 |
||
| 300 |
_a73-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aDihydropyridines _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aOcon, J | |
| 700 | 1 | _aGomez, C F | |
| 700 | 1 | _aManjon, M | |
| 700 | 1 | _aPastor, L | |
| 700 | 1 | _aHerrera, J | |
| 700 | 1 | _aVillatoro, J | |
| 700 | 1 | _aCalls, J | |
| 700 | 1 | _aTorrijos, J | |
| 700 | 1 | _aRodrÃguez, V I | |
| 700 | 1 | _aRodriguez, M M A | |
| 700 | 1 | _aMendez, M L | |
| 700 | 1 | _aMorey, A | |
| 700 | 1 | _aMartinez, F I | |
| 700 | 1 | _aMarco, J | |
| 700 | 1 | _aLiebana, A | |
| 700 | 1 | _aRincon, B | |
| 700 | 1 | _aTornero, F | |
| 773 | 0 |
_tRenal failure _gvol. 27 _gno. 1 _gp. 73-80 |
|
| 999 |
_c15393076 _d15393076 |
||